Differentiating antidepressants of the future: efficacy and safety

There have been significant advances in the treatment of depression since the serendipitous discovery that modulating monoaminergic neurotransmission may be a pathological underpinning of the disease. Despite these advances, particularly over the last 15years with the introduction of selective serot...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacology & therapeutics (Oxford) 2007-01, Vol.113 (1), p.134
Hauptverfasser:	Rosenzweig-Lipson, Sharon, Beyer, Chad E, Hughes, Zoë A, Khawaja, Xavier, Rajarao, Somana J, Malberg, Jessica E, Rahman, Zia, Ring, Robert H, Schechter, Lee E
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antidepressive Agents - adverse effects Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Cardiovascular Diseases - chemically induced Cognition - drug effects Depression - complications Depression - drug therapy Drug Design Drug Evaluation, Preclinical - methods Humans Pain - complications Pain - drug therapy Patient Compliance Sexual Dysfunction, Physiological - chemically induced Treatment Failure Vomiting - chemically induced Weight Gain - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!